Platelet-activating factor production in the stimulated macrophages is enhanced by the cyclooxygenase inhibitors.
Yamada
M
M
Department of Pathophysiological Biochemistry, Faculty of Pharmaceutical Sciences, Tohoku University, Miyagi, Japan.
Watanabe
M
M
Mue
S
S
Ohuchi
K
K
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D015232:Dinoprostone / Q000096:biosynthesis / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000378:metabolism; D010972:Platelet Activating Factor / Q000096:biosynthesis*; D051381:Rats; D013268:Stimulation, Chemical; D019284:Thapsigargin / Q000494:pharmacology
D016861:Cyclooxygenase Inhibitors; D004791:Enzyme Inhibitors; D010972:Platelet Activating Factor; D003994:Bucladesine; D019284:Thapsigargin; D015232:Dinoprostone; D007213:Indomethacin